Urinary incontinence in men

Impact of urinary incontinence. Cause of urinary incontinence in men. Mechanisms underlying development of postprostatectomy incontinence. Behavioral, pharmacological therapies and internal appliances in treatment of urinary incontinence in the men.

Рубрика Медицина
Вид статья
Язык английский
Дата добавления 13.04.2023
Размер файла 54,7 K

Отправить свою хорошую работу в базу знаний просто. Используйте форму, расположенную ниже

Студенты, аспиранты, молодые ученые, использующие базу знаний в своей учебе и работе, будут вам очень благодарны.

Размещено на http://www.allbest.ru/

Catholic University in Ruzomberok, Faculty of Health, Slovakia

Urinary incontinence in men

Babecka Jozef

Introduction

Urinary incontinence has a significant psychosocial impact in men, reducing their quality of life. It has been less thoroughly investigated than incontinence in women; nevertheless, a detailed history and physical examination to classify the type of incontinence are key to guiding management. Urinary incontinence is defined by the International Continence Society as `the complaint of any involuntary loss of urine'.

Several types of urinary incontinence have been defined in the adult male, the most common being urgency urinary incontinence, stress urinary incontinence and mixed urinary incontinence (see Table). In clinical practice, it is often the case that a patient presents with features of more than one type of incontinence, along with a variety of underlying disease processes. Nevertheless, it is useful to make such classifications as each type of incontinence has different aetiologies, clinical manifestations and treatments.

Table.

Types of urinary incontinence (Source: Mangir, N., 2020)

International Continence Society term

Definition

Urgency urinary incontinence

The complaint of involuntary loss of urine associated with urgency

Stress urinary incontinence

The complaint of involuntary loss of urine on effort or physical exertion including sporting activities, sneezing or coughing

Mixed urinary incontinence

The complaint of both stress and urgency urinary incontinence, ie involuntary loss of urine associated with urgency as well as with effort or physical exertion including sporting activities, sneezing or coughing (stress)

Enuresis

The complaint of intermittent (non-continuous) incontinence that occurs during periods of sleep

Continuous urinary incontinence

The complaint of continuous involuntary loss of urine

Insensible urinary incontinence

The complaint of urinary incontinence where the individual is aware of urine leakage but unaware of how or when it occurred

Postural urinary incontinence

The complaint of urinary incontinence during change of posture or position, eg from supine or seated to standing

Disability associated incontinence

The complaint of urinary incontinence in the presence of a functional inability to reach a toilet/urinal in time because of a physical (eg orthopaedic, neurological) and/or mental impairment

Overflow incontinence

The complaint of urinary incontinence in the symptomatic presence of an excessively full bladder (no cause identified)

Sexual arousal incontinence

The complaint of involuntary loss of urine during sexual arousal, foreplay and/or masturbation

Climacturia

The complaint of involuntary loss of urine at the time of orgasm

Post-voiding incontinence

The complaint of a further involuntary passage (incontinence) of urine or dribbling following the completion of voiding

Impact of urinary incontinence

Urinary incontinence has a significant impact on the patient, family members and healthcare system. In men it has been less thoroughly investigated than incontinence in women, due to the assumption that male incontinence is less of a problem socioeconomically and epidemiologically. However, urinary incontinence has a significant psychosocial impact in men, reducing their quality of life with abstinence from daily activities and higher rates of depression.

Every year around 100 million adult men are affected by incontinence worldwide. The prevalence of urinary incontinence in men increases with age, although prevalence rates are nearly half those of women in the same age group. However, men are also more reluctant to seek help for their incontinence problem compared with women. For example, in a population-based study conducted in the EU, 22% of men in the community who experience an episode of incontinence per week sought care, compared with 45% of women (Babecka 2021).

Cause of urinary incontinence in men

Urgency urinary incontinence is the most common cause of urinary incontinence in men. Patients typically experience a `sudden and compelling desire to pass urine that is difficult to defer', which may result in urine leakage. Urgency urinary incontinence in men is typically associated with bladder overactivity (overactive bladder syndrome) and/or obstruction to urine flow as a result of benign prostatic enlargement (bladder outlet obstruction).

The specific mechanisms underlying urgency urinary incontinence are not completely understood. However, the pathophysiology involves involuntary bladder contractions (detrusor overactivity), which can be measured during urodynamic studies (Wilson, 2016). Detrusor overactivity could be due to a defect in afferent sensory signalling from the urinary tract, a defective central processing of these signals, and/or it can be a primary problem of the detrusor muscle. Other factors such as age, previous pelvic surgery and comorbidities such as diabetes and hypertension may also play a role in development of detrusor overactivity. However, only age has been shown to be an independent risk factor for bladder overactivity. Epidemiological studies demonstrate that symptoms of bladder overactivity increase with age, independent of other factors in both men and women.

Bladder outlet obstruction is shown to cause bladder overactivity. Research has demonstrated several mechanisms by which bladder outlet obstruction can cause detrusor activity. These include detrusor smooth muscle hypertrophy, hypertrophy of afferent and efferent nerves, and denervation hypersensitivity. Accordingly, clinical experience shows that prostate surgery for benign prostatic enlargement to relieve the outflow obstruction (namely, transurethral resection of the prostate), improves bladder overactivity symptoms in 70-80% of patients.

On the other hand, stress urinary incontinence in men almost invariably develops due to previous prostate surgery (post-prostatectomy incontinence). The most common cause of persistent stress urinary incontinence in men is radical prostatectomy, with incontinence rates between 10 and 25%. Other causes of stress incontinence in men could be severe pelvic trauma and neurological diseases that damage the external sphincter mechanism (Gulasova, Babecka, 2020).

Mechanisms underlying development of postprostatectomy incontinence

Our understanding of how urinary incontinence develops after surgery for prostate cancer (radical prostatectomy) is still evolving. Although postprostatectomy incontinence has been broadly explained to occur as a result of damage to the external urethral sphincter mechanism during surgery, slightly different mechanisms are probably responsible for failure of sphincteric functions after surgery for benign disease and malignant disease.

Stress urinary incontinence after surgery for benign prostatic disease can be a result of direct damage to the external sphincter mechanism (the striated muscle), or the prostate surgery stimulates a pre-existing incompetence of the distal urethral sphincter after ablation of the proximal sphincter mechanism. Factors predisposing to distal sphincteric damage involve pelvic trauma, denervation from pelvic surgery, intervertebral disc disease and radical radiotherapy. The other factor is injury sustained during surgery, such as neural injury or sphincteric denervation.

Different mechanisms play a role in the development of urinary incontinence after surgery for prostate cancer. Recent advancements in robotic surgeries have probably improved our understanding of the pathophysiology of post-prostatectomy incontinence. Research has shown that perioperative factors such as membranous urethral length, reconstruction of periurethral support structures, preservation of bladder neck and the neurovascular bundles also play a key role in development of urinary incontinence after radical prostatectomy.8 Patient-related factors such as age, body mass index (BMI), prostate size and presence of other functional bladder problems before surgery have also been thought to play a role. The external sphincter mechanism is often not damaged following radical prostatectomy (Gulasova, Babecka, 2020).

Methods

The article meeting the criteria for inclusion in this appraisal were evaluated and entered into the Synthesis Matrix. The study findings that answered the research question were assessed and grouped into therapies. A critical appraisal of the literature sought to determine best practices in the treatment of male UI. An evidence table served as a guide to answer the study question “What are the most current and best evidencebased practice treatments for males with Urinary Incontinence?” The elements within the table included evidence type, sample size, study findings that helped answer the research question, limitations, and evidence rating. The sources included Medline (PubMed), Cumulative Index to Nursing and Allied Heath Literature (CINHAL), PsycINFO, Cochrane Library, ProQuest, DynaMed, Google Scholar, Arctic Health Publications Database, and Nursing Commons.

Results

Urgency urinary incontinence. The first-line treatment of urgency urinary incontinence involves bladder retraining and behavioural therapy. If these measures fail, anticholinergic therapy can be used. In cases where medical therapy fails, the treatment options include intradetrusor botulinum toxin injections or neuromodulation.

Stress urinary incontinence. First-line treatment for men with stress urinary incontinence is conservative. This involves behavioural therapy and pelvic floor muscle training/ pelvic physiotherapy. Behavioural interventions are mostly supportive measures in this setting that mainly involve weight loss for patients with a high BMI. Surgical treatment can be considered if conservative measures fail. Generally, any surgical intervention is postponed for 6-12 months after surgery. Surgical treatment options include peri-urethral bulking agents, urethral slings and artificial urinary sphincters. Artificial sphincter is the gold standard treatment option for post-prostatectomy incontinence, with continence rates after surgery being more than 80%.

Mixed urinary incontinence has components of both urgency and stress incontinence. Management first requires the clinician to determine the most bothersome complaint of the patient. It often involves a combination approach by a specialist, as the treatment of one may make the other worse. Continuous urinary incontinence. It may suggest the development of a fistula between the urethra beyond the distal sphincteric mechanism, or a grossly deficient sphincteric mechanism leading to no restriction of flow. Management of this condition involves surgery or continence devices.

Behavioral Therapies in the treatment of UI

Much of the literature substantiates the use of Behavioral Therapy as first-line treatment of UI in males (Babecka, 2020). These treatments have been found to be the least invasive and have few side effects (Vansac, 2019).

Behavioral interventions for UI in men with prostate diseases were examined in ten studies. The continence rates in the control groups increased to more than 62% across all trials after the intervention (Markland et al., 2010).

A treatment plan starts with lifestyle modifications;

- reducing caffeine and carbonated drinks,

- avoiding constipation by eating well,

- and establishing a predictable bowel pattern that would also avoid straining (Fawcett, 2014).

Despite the documented usefulness of Behavioral Therapies, these lifestyle modifications may not be enough. Considering another strategy, Pelvic Floor Exercises (PFE) can be taught to men with leakage or over-activity symptoms (Fawcett, 2012). Moore and Lucas (2010) found that PFE reduced the frequency and amount of UI and the time to reach a continent state.

However, Moore and Lucas also concluded that PFE has limited benefits in patients with severe UI and there is no long-term benefit of PFE training as continence rates leveled after one year. According to Shelly (2016), individualized PFE training can significantly improve symptoms of prolapse and incontinence, but it can be difficult for patients to learn how to isolate these muscles to exercise them properly. Therefore, many patients who are affected by Pelvic Floor Muscle dysfunctions, requiring skilled therapy for successful rehabilitation (Shelly, 2016).

Besides PFE, Stothers et al. (2010) found biofeedback and bladder training to be useful as additional noninvasive, behavioral options. They may be used both for cognitively impaired/institutionalized patients and for independently living, cognitively-aware geriatric patients able to participate in learning new skills. There is a considerable body of scientific evidence supporting the effectiveness of behavioral therapy, but most subjects in the studies were women (Stothers et al., 2010).

Another method of training included timed or scheduled voiding. According to Testa (2015), voiding empties the bladder before incontinence can occur and limits the amount of urine in the bladder affected by stress movements. Voiding on a routine schedule, allows the bladder to fill while avoiding distention and resulting UI. Timing of the void can be individualized to best match an individual's habits and schedule (Testa, 2015).

Finally, adjustments in lifestyle can significantly impact the incidence of UI in adults. Testa (2015) further stated that weight loss has shown to improve UI in obese women because extra abdominal weight places greater force on the bladder. Smoking tobacco contributed to UI through irritating effects on the bladder and increased abdominal pressure during times of respiratory infections and cough. Balancing fluid intake involved achieving appropriate daily consumption while limiting fluids before bedtime; however, older individuals with UI should not be severely fluid restricted due to risk of dehydration and hypotension (Testa, 2010). First-line management plans should include behavioral therapy with lifestyle adjustments followed by pharmacologic treatment (Popovicova et., al, 2021).

urinary incontinence therapy man

Pharmacological Therapy in the treatment of UI

Stothers et al., (2010) found that anticholinergic drugs such as oxybutynin and tolterodine were effective in treating incontinence. Anticholinergic medications, which competitively bind to muscarinic cholinergic receptors (M2/M3) on the bladder, decreased the intensity of bladder contractions and urgency (Testa, 2010). While these medications improved UI symptoms, inhibition of M receptors outside of the bladder may cause unwanted side effects in the older adult, such as blurred vision, dry eyes, dry mouth, constipation, tachycardia, and cognitive impairment. Therefore, anticholinergic medications should be strictly regulated in the geriatric patient, started at the lowest possible dose and discontinued if poorly tolerated (Testa, 2010).

Other pharmacologic treatments for UI included antidepressants, muscarinic antagonists, and adrenergic antagonists (Markland et al., 2010). Medications with alpha agonistic properties have been shown to mildly increase the tone of the urethral sphincter. However, such medications have been used off-label because the clinical efficacy of these drugs in UI is limited (Testa, 2010). And recently, a new class of medication for overactive bladder (OAB) has been approved by the FDA. While anticholinergics work by blocking the muscarinic receptors of the detrusor muscle, these medications often have bothersome systemic side effects, including dry mouth, constipation, and confusion. The bladder also contains P-3 adrenoreceptors that promote active relaxation of the detrusor muscle. A p-3 agonist, mirabegron, has been developed and has been approved for use and has an indication for OAB (Weber, 2015).

The drug duloxetine with proven efficacy in females with UI seems to be effective in male UI as well. Duloxetine, a selective serotonin-noradrenalin reuptake inhibitor, is a recognized pharmacological therapy used in the management of UI (Moore and Lucas, 2010). Although studies of duloxetine are limited, evidence does suggest that there might be a place for this drug in the management of men with stress UI in the future. Duloxetine does not have FDA approval for SUI and has been used off label. (Tsarkis et al, 2008). Additionally, some patients complained of severe side effects, mainly massive fatigue or insomnia (Moore and Lucas, 2010).

Containment

Containment is a necessary aspect of incontinence care, and at times it is the only management option (Babecka, 2021). Containment is necessary where other treatments have failed, and skin integrity is at risk (Belovicova, Vansac, 2019). Where containment is the only option to manage male urinary incontinence, options available include the following:

- Washable boxer shorts/YFronts

- Body-worn pad

- Mesh Pants

- Dribble Pouches

- Conduction Aids

In her opinion article, Wilson (2016) described incontinence pads as preventing urine from contaminating clothing, furniture, and bedding, thereby allowing the individual to keep the symptoms private. Pad selection depended on the amount of urine loss and when, during the day and night, it is experienced. She posited “it is the role of the assessor, guided by the patient, alongside the information gathered during the assessment, to make the appropriate choice”. The patient should use the smallest pad that is suitable for urine loss. Another option is washable pads and pants; they are particularly appropriate where patients experience skin reactions to disposable pads. For men, there are various disposable and washable dribble pouches, worn over the penis. There are also disposable pads and washable, stay-dry sheets available, for the bed and the chair (Gulasova, Babecka, 2020).


Подобные документы

  • Gastroesophageal reflux disease. Factors contributing to its the development. Esophageal symptoms of GERD. Aim of treatment. Change the life style. A basic medical treatment for GERD includes the use of prokinetic drugs with antisecretory agents.

    презентация [390,7 K], добавлен 27.03.2016

  • The concept and the main causes of atherosclerosis, primary symptom. The mechanisms of atherosclerosis, main causes The symptoms and consequences, prevention. Atherosclerosis treatments. Basic approaches to diagnosis and treatment of this disease.

    презентация [813,1 K], добавлен 21.11.2013

  • Risk Factors. The following symptoms may indicate advanced disease. A barium contrast study of the small intestine. Surgical removal is the primary treatment for cancer of the small intestine. The association of small bowel cancer with underlying.

    презентация [4,1 M], добавлен 28.04.2014

  • Etiology and pathogenesis, types, treatment of pulpits. Inflammation of dental pulp. An infection (microorganisms) which penetrats in the cavity of pulp chamber. Test of healthy pulp. Tapping of tooth directly. Root canal treatment. Tooth extraction.

    презентация [851,9 K], добавлен 31.05.2016

  • The development of modern medicine. The creation of internal organs, implants. The use of modern orthopaedics mechanical devices. The replacement of lost parts of the human body by means of surgical operations. Bridge denture. The use of prostheses.

    презентация [5,0 M], добавлен 31.05.2016

  • Agranulocytosis - pathologic condition, which is characterized by a greatly decreased number of circulating neutrophils. Epidemiology and pathophysiology of this disease. Hereditary disease due to genetic mutations. Signs and symptoms, treatment.

    презентация [1,8 M], добавлен 25.02.2014

  • Teratology is the science of the etiology, pathogenesis, clinical and morphological characteristics, prevention and treatment of congenital malformations. History and the stages of its formation and development. Etiology of congenital malformations.

    презентация [873,8 K], добавлен 23.09.2014

  • Pneumonia is an inflammatory condition of the lung—affecting primarily the microscopic air sacs known as alveoli. The bacterium Streptococcus pneumoniae is a common cause of pneumonia. Symptoms, diagnostics, treatment and prevention of this disease.

    презентация [279,8 K], добавлен 12.11.2013

  • Concept and characteristics of focal pneumonia, her clinical picture and background. The approaches to the diagnosis and treatment of this disease, used drugs and techniques. Recent advances in the study of focal pneumonia. The forecast for recovery.

    презентация [1,5 M], добавлен 10.11.2015

  • The main features of uterine fibroids. The development of a tumor from the "embryonic growth site" and a microscopic nodule without signs of cellular differentiation to a macroscopic nodule. Study of surgical and conservative treatment of leiomyoma.

    презентация [1,4 M], добавлен 31.10.2021

Работы в архивах красиво оформлены согласно требованиям ВУЗов и содержат рисунки, диаграммы, формулы и т.д.
PPT, PPTX и PDF-файлы представлены только в архивах.
Рекомендуем скачать работу.